Related Experiment Video
Updated: May 10, 2026

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease
Xia Zhou1, Lucy X Fan, William E Sweeney
1Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas 66160, USA.
Abstract:
Autosomal-dominant polycystic kidney disease (ADPKD) is caused by mutations in either PKD1 or PKD2 and is characterized by the development of multiple bilateral renal cysts that replace normal kidney tissue. Here, we used Pkd1 mutant mouse models to demonstrate that the nicotinamide adenine dinucleotide-dependent (NAD-dependent) protein deacetylase sirtuin 1 (SIRT1) is involved in the pathophysiology of ADPKD. SIRT1 was upregulated through c-MYC in embryonic and postnatal Pkd1-mutant mouse renal epithelial cells and tissues and could be induced by TNF-α, which is present in cyst fluid during cyst development. Double conditional knockouts of Pkd1 and Sirt1 demonstrated delayed renal cyst formation in postnatal mouse kidneys compared with mice with single conditional knockout of Pkd1. Furthermore, treatment with a pan-sirtuin inhibitor (nicotinamide) or a SIRT1-specific inhibitor (EX-527) delayed cyst growth in Pkd1 knockout mouse embryonic kidneys, Pkd1 conditional knockout postnatal kidneys, and Pkd1 hypomorphic kidneys. Increased SIRT1 expression in Pkd1 mutant renal epithelial cells regulated cystic epithelial cell proliferation through deacetylation and phosphorylation of Rb and regulated cystic epithelial cell death through deacetylation of p53. This newly identified role of SIRT1 signaling in cystic renal epithelial cells provides the opportunity to develop unique therapeutic strategies for ADPKD.
Insights
Autosomal-dominant polycystic kidney disease (ADPKD) involves Sirtuin 1 (SIRT1) in kidney cyst development. Inhibiting SIRT1 slowed cyst growth in mouse models, offering new therapeutic targets for ADPKD.
Area of Science:
- Nephrology
- Molecular Biology
- Genetics
Background:
- Autosomal-dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by renal cyst formation, caused by mutations in PKD1 or PKD2.
- The exact molecular mechanisms driving cystogenesis in ADPKD are not fully understood.
Purpose of the Study:
- To investigate the role of nicotinamide adenine dinucleotide-dependent (NAD-dependent) protein deacetylase sirtuin 1 (SIRT1) in the pathophysiology of ADPKD.
- To evaluate the therapeutic potential of SIRT1 inhibition in ADPKD mouse models.
Main Methods:
- Utilized Pkd1 mutant mouse models (embryonic, postnatal, hypomorphic) to study ADPKD.
- Examined SIRT1 expression levels and its regulation by c-MYC and TNF-α.
- Administered pan-sirtuin and SIRT1-specific inhibitors (nicotinamide, EX-527) to assess cyst growth.
- Analyzed the impact of SIRT1 on cell proliferation and death via Rb and p53 pathways.
Main Results:
- SIRT1 was upregulated in Pkd1-mutant renal epithelial cells and tissues.
- Genetic deletion or pharmacological inhibition of SIRT1 significantly delayed renal cyst formation and growth in various Pkd1 mutant mouse models.
- SIRT1 regulates cystic epithelial cell proliferation and apoptosis through deacetylation and phosphorylation of Rb and p53.
Conclusions:
- SIRT1 plays a critical role in ADPKD pathogenesis by influencing cystic epithelial cell behavior.
- Targeting SIRT1 signaling presents a promising therapeutic strategy for treating ADPKD.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
Chronic Kidney Disease I: Introduction
Nephrons

